3,4,7-Trihydroxyisoflavone

CAS No. 485-63-2

3,4,7-Trihydroxyisoflavone( —— )

Catalog No. M32122 CAS No. 485-63-2

3',4',7-Trihydroxyisoflavone is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    3,4,7-Trihydroxyisoflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    3',4',7-Trihydroxyisoflavone is a natural product.
  • Description
    3',4',7-Trihydroxyisoflavone is a natural product.
  • In Vitro
    7,3',4'-Trihydroxyisoflavone triggers cell cycle arrest at the G1 phase and displays an anti-proliferative effect against EGF receptor-positive skin cancer. 7,3',4'-Trihydroxyisoflavone also significantly inhibits UVB-induced COX-2 expression by suppressing the NF-B transcription activity in mouse skin epidermal JB6 P+ cells.
  • In Vivo
    In a mouse skin tumorigenesis model, 7,3',4'-Trihydroxyisoflavone strongly suppresses the incidence, multiplicity, and volume of UVB-induced mouse skin tumors. Consistent with the tumor data, 7,3',4'-Trihydroxyisoflavone clearly attenuates UVB-induced COX-2 expression in hairless mouse skin.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    485-63-2
  • Formula Weight
    270.2
  • Molecular Formula
    C15H10O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (370.04 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AP1903

    AP1903 (Rimiducid, AP-1903) is a potent, specific synthetic ligand of FKBP Phe36Val mutant (F36V-FKBP) with binding IC50 of 1.8 nM.

  • N-trans-p-coumaroylo...

    N-trans-p-coumaroyloctopamine is derived from the tuber tissue of potatoes.

  • Mirificin

    Puerarin has been investigated for the treatment of Alcohol Abuse.